Trending today
Load more
Login / Create account for advanced features
Generating your feed, please be patient ...
Latest news
Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18-64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials - PubMed | Zootzle